News

Viad Corp Sells GES for $535M, Sets Focus on Hospitality

Viad Corp Sells GES for $535M, Sets Focus on Hospitality

Viad Corp's Strategic Sale of GES for $535 Million

Viad Corp (NYSE: VVI) has recently made headlines as its shares surge following the announcement of a significant deal to sell its GES business to Truelink Capital for an impressive $535 million. This move is a pivotal shift for the company, aimed at redefining its identity and operations within the attractions and hospitality sector.

Details of the GES Transaction

The sale price of $535 million will undergo adjustments based on cash, debt, debt-like items, and normalized working capital, with the full amount scheduled to be paid in cash.

Of this total, $25 million is marked for deferral for a year after the closing, contingent on the mere passage of time. This strategic decision sets the path for Viad to streamline its operations and focus on its core business.

Separation from GES Business

With this transaction, GES will separate from Viad’s Pursuit attractions and hospitality segment. Until the transaction receives final approval, GES and Pursuit will continue to function under the Viad umbrella, ensuring a smooth transition to Truelink’s portfolio.

Rebranding as Pursuit

Following the completion of the sale, Viad plans to rebrand as Pursuit. This rebranding comes with the exciting change of its NYSE ticker symbol to PRSU, reflecting its renewed focus on the attractions and hospitality market.

Performance Highlights of Pursuit

Notably, in the current year, Pursuit's attractions have drawn in 3.5 million visitors, highlighting its significant appeal and reach. Pursuit hosts nearly 420,000 room nights, contributing to a substantial revenue generation of $350 million, complemented by an impressive Adjusted EBITDA margin of 26.4%.

Financial Strategy Post-Transaction

The transaction is anticipated to finalize by the end of 2024, subject to regulatory approvals and customary closing conditions. Once completed, the cash proceeds will be directed toward retiring Viad’s 2021 Credit Facility, which includes a hefty $317 million outstanding Term Loan B, alongside a revolving credit facility amounting to $170 million, which remains untapped as of the last report.

Statements from Leadership

Steve Moster, Viad’s President and Chief Executive Officer, commented on the strategic move, stating, “Both Pursuit and GES have seen significant demand and achieved remarkable results. After a decade-long growth journey, Pursuit is now an industry leader with the assets, resources, and capabilities to stand on its own.”

Moster added that this transformative sale is aimed at establishing Pursuit as a pure-play, high-growth, and high-return business, poised to leverage its financial strength for growth opportunities in the hospitality and attractions space.

Market Response

As a reflection of the positive market sentiment following the announcement, shares of VVI rose by 17.2%, reaching $41.93. This uptick indicates investor confidence in Viad's strategic direction and potential for future growth.

Frequently Asked Questions

What is the amount Viad Corp is selling GES for?

Viad Corp is selling its GES business for $535 million.

What will happen to the GES business after the sale?

GES will transition to Truelink Capital, while Pursuit will continue under Viad until the deal is finalized.

What is Viad's new ticker symbol after rebranding?

After the sale, Viad plans to change its NYSE ticker symbol to PRSU as part of its rebranding to Pursuit.

How many visitors did Pursuit attract recently?

Pursuit attracted 3.5 million visitors to its attractions in the recent year.

When is the transaction expected to finalize?

The transaction is expected to close by the end of 2024, pending regulatory approvals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading

Top 5 Most Recently Viewed Articles

Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 21

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Merck's Major Investment to Enhance U.S. Vaccine Production

Updated Category News Views 769

Merck's $1 Billion Expansion for Vaccine Production Merck & Co Inc (NYSE: MRK) recently made headlines with its announcement of a new $1 billion facility dedicated to vaccine manufacturing. This impressive 225,000-square-foot site, located in Durham, represents a significant leap forward in the company’s ongoing commitment to enhance its production capabilities in the...

Continue Reading
Conduit Pharmaceuticals Launches $1 Million Stock Repurchase Plan

Updated Category News Views 193

Conduit Pharmaceuticals Unveils Strategic Share Repurchase Program NAPLES, Fla. and CAMBRIDGE, United Kingdom — Conduit Pharmaceuticals Inc. (NASDAQ: CDT) recently announced the approval of a significant share repurchase initiative, allowing the Company to buy back up to $1,000,000 worth of its outstanding common stock. This program underscores the Board of Directors’...

Continue Reading
Jeffrey Katzenberg Invests in AI for Child Safety Amid Meta Critique

Updated Category News Views 295

Jeffrey Katzenberg's Support for AI Solutions Former DreamWorks CEO and founding partner of WndrCo, Jeffrey Katzenberg, is taking significant steps towards improving child safety online. This is particularly relevant as he invests in Aura, a startup that focuses on artificial intelligence-driven solutions amidst increasing regulatory scrutiny on Meta Platforms Inc. for...

Continue Reading
CrossCountry Mortgage Achieves Top Recognition for Originators

Updated Category News Views 278

CrossCountry Mortgage Leads the Way in Outstanding Originations CrossCountry Mortgage (CCM) has proudly announced its remarkable achievement of having the highest number of originators recognized on the Scotsman Guide Top Originators list for 2025. This prestigious honor celebrates an impressive tally of 504 loan officers from CCM, more than any competing lender,...

Continue Reading